Status:
UNKNOWN
Impact of Spiroergometer Parameters as Diagnostic Marker of Cardiac Ischemia in Pts. With Stable Angina Compared to FFR.
Lead Sponsor:
Jena University Hospital
Conditions:
Stable Angina
Eligibility:
All Genders
18+ years
Brief Summary
In Patients with stable Angina pectoris CCS 1-3 exercise testing for ischemia detection is widely used despite the known limitations. Measurement of the FFR is invasive but gold standard for Ischemia ...
Eligibility Criteria
Inclusion
- stable Angina (CCS \>1-3) with suspected CAD or
- dyspnoea at exertion NYHA \>2 or
- signs of ischemia within SPECT or exercise electrocardiography
- willingness to participate in the trial
Exclusion
- Unstable angina or myocardial infarction within the last 2 weeks
- inability to perform bicycle exercise test
- significant valvular disease
- HOCM
- av- block \>I degree
- asthma bronchiales
Key Trial Info
Start Date :
January 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04450459
Start Date
January 2 2019
End Date
June 1 2023
Last Update
August 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universityhospital
Jena, Germany, 07747